BioCentury | Jul 13, 2018
Clinical News

HPV testing improves cervical intraepithelial neoplasia detection vs. liquid-based cytology

...Qiagen N.V. (Xetra:QIA; NYSE:QGEN), Venlo, the Netherlands Product: Hybrid Capture 2 High-Risk HPV DNA Test (Digene...
...NA Jaime De Leon Hybrid Capture 2 High-Risk HPV DNA Test (digene hc2 hpv dna test, Digene, Digene...
BioCentury | Apr 21, 2014
Company News

Qiagen diagnostic news

...which will become the manufacturing site for some of its highest-volume diagnostic assays, including the Digene...
BioCentury | Mar 16, 2012
Company News

HPV testing included in cervical cancer screening guidelines

...the American Society for Clinical Pathology Screening. Approved tests for HPV in the U.S. include: Digene...
BioCentury | Mar 12, 2012
Company News

KingMed, Qiagen sales and marketing update

...Qiagen and KingMed will co-market Qiagen's Digene HPV test in China. Qiagen, which said partnering with...
BioCentury | Oct 31, 2011
Regulation

Lessons from PSA debate

...not be used in women under 30. There are three tests for high-risk HPV detection: Digene...
BioCentury | Oct 20, 2011
Politics & Policy

Panel releases draft update to HPV screening recommendations

...30 years and older as a risk assessment or patient management tool. The tests are: Digene...
BioCentury | Oct 19, 2011
Politics & Policy

Task force set to update cervical cancer screening guidelines

...30 years and older as a risk assessment or patient management tool. The tests are: Digene...
BioCentury | Sep 26, 2011
Clinical News

HPV E6 test: Interim data

...ninefold reduction in the referral rate for women requiring follow-up and/or treatment compared to the digene...
...value (PPV) of the HPV E6 Test was 33.3% vs. 5.1% and 5.6% for the digene...
...Test with the careHPV test and VIA. Women were also screened at enrollment with the digene...
BioCentury | Sep 20, 2011
Clinical News

Arbor Vita reports HPV test data

...ninefold reduction in the referral rate for women requiring follow-up and/or treatment compared to the digene...
...Test with the careHPV test and VIA. Women were also screened at enrollment with the digene...
...and conducted by the Chinese Academy of Medical Sciences. Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) markets the digene...
BioCentury | May 2, 2011
Product Development

Differentiating in HPV

...with equivocal cytology, cobas HPV Test is as sensitive and specific as Qiagen N.V. 's digene...
Items per page:
1 - 10 of 237
BioCentury | Jul 13, 2018
Clinical News

HPV testing improves cervical intraepithelial neoplasia detection vs. liquid-based cytology

...Qiagen N.V. (Xetra:QIA; NYSE:QGEN), Venlo, the Netherlands Product: Hybrid Capture 2 High-Risk HPV DNA Test (Digene...
...NA Jaime De Leon Hybrid Capture 2 High-Risk HPV DNA Test (digene hc2 hpv dna test, Digene, Digene...
BioCentury | Apr 21, 2014
Company News

Qiagen diagnostic news

...which will become the manufacturing site for some of its highest-volume diagnostic assays, including the Digene...
BioCentury | Mar 16, 2012
Company News

HPV testing included in cervical cancer screening guidelines

...the American Society for Clinical Pathology Screening. Approved tests for HPV in the U.S. include: Digene...
BioCentury | Mar 12, 2012
Company News

KingMed, Qiagen sales and marketing update

...Qiagen and KingMed will co-market Qiagen's Digene HPV test in China. Qiagen, which said partnering with...
BioCentury | Oct 31, 2011
Regulation

Lessons from PSA debate

...not be used in women under 30. There are three tests for high-risk HPV detection: Digene...
BioCentury | Oct 20, 2011
Politics & Policy

Panel releases draft update to HPV screening recommendations

...30 years and older as a risk assessment or patient management tool. The tests are: Digene...
BioCentury | Oct 19, 2011
Politics & Policy

Task force set to update cervical cancer screening guidelines

...30 years and older as a risk assessment or patient management tool. The tests are: Digene...
BioCentury | Sep 26, 2011
Clinical News

HPV E6 test: Interim data

...ninefold reduction in the referral rate for women requiring follow-up and/or treatment compared to the digene...
...value (PPV) of the HPV E6 Test was 33.3% vs. 5.1% and 5.6% for the digene...
...Test with the careHPV test and VIA. Women were also screened at enrollment with the digene...
BioCentury | Sep 20, 2011
Clinical News

Arbor Vita reports HPV test data

...ninefold reduction in the referral rate for women requiring follow-up and/or treatment compared to the digene...
...Test with the careHPV test and VIA. Women were also screened at enrollment with the digene...
...and conducted by the Chinese Academy of Medical Sciences. Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) markets the digene...
BioCentury | May 2, 2011
Product Development

Differentiating in HPV

...with equivocal cytology, cobas HPV Test is as sensitive and specific as Qiagen N.V. 's digene...
Items per page:
1 - 10 of 237